Process for treatment and prevention of ventricular fibrillation

Details Process for treatment and prevention of ventricular fibrillation Process for treatment and prevention of ventricular fibrillation

1980-02-19

1981-06-02

Cacciapaglia, Jr., Frank

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

424259, 424263, 424273R, A61K 31195, A61K 3149, A61K 3144, A61K 31415

Patent

active

042711924

ABSTRACT:
The risk of ventricular fibrillation in animals is reduced by administering tyrosine, a tyrosine precursor, threonine or mixtures thereof, either alone or in combination with a substance which is known to reduce the risk of ventricular fibrillation. A novel composition is provided comprising a unit dosage form of tyrosine, a precursor for tyrosine, threonine or mixtures thereof and a substance which is known to reduce the risk of ventricular fibrillation.

REFERENCES:
patent: 3651237 (1972-03-01), Laborit
patent: 3692827 (1972-09-01), Garzia
patent: 3769335 (1973-10-01), Garzia
C. A. 87: 131187k, 1977.
C. A. 82: 25836h, 1975.

Affiliated with

Also associated with

Rating

Process for treatment and prevention of ventricular fibrillation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for treatment and prevention of ventricular fibrillation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for treatment and prevention of ventricular fibrillation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1865358